Last mentioned: Mar 18, 2026
Clinical Pilot Phase
Anticipated start of pilot programs to validate predictive accuracy in academic medical centers.
Multi-Modal Integration
Expected expansion of models to include longitudinal imaging and spatial transcriptomics data.
MIT Research Release
MIT researchers publish the '3 Questions' framework for tumor progression modeling.
MIT's Elenna Dugundji highlights that data quality and governance are the primary drivers of successful AI implementation in supply chains. Without rigorous data discipline, advanced algorithms fail to deliver meaningful optimization, reinforcing the 'Garbage In, AI Out' paradigm.
MIT researchers have introduced a sophisticated framework for building predictive models that characterize the complex trajectory of tumor progression. By merging computational biology with deep learning, these models aim to forecast how cancers evolve and develop drug resistance, offering a new frontier for personalized oncology.